Co-Crystals Comprising Levothyroxine And A Dicarboxylic Acid

    公开(公告)号:US20210395186A1

    公开(公告)日:2021-12-23

    申请号:US17285653

    申请日:2019-10-16

    申请人: Sandoz AG

    IPC分类号: C07C229/36 C07C55/02

    摘要: The present invention relates to co-crystals comprising levothyroxine and a dicarboxylic acid, preferably L-tartaric acid or oxalic acid, and processes for the preparation thereof. Furthermore, the invention relates to a pharmaceutical composition comprising a co-crystal of the present invention, preferably the co-crystal comprising levothyroxine and L-tartaric acid or oxalic acid, and at least one pharmaceutically acceptable excipient. The pharmaceutical composition of the present invention can be used as a medicament, in particular for the treatment of hypothyroidism.

    Aliphatic Materials and Uses Thereof in Heating and Cooling Applications

    公开(公告)号:US20190033009A1

    公开(公告)日:2019-01-31

    申请号:US16023073

    申请日:2018-06-29

    发明人: Paul Bertin

    摘要: Aliphatic materials and their use in passive heating and cooling applications are generally disclosed. In some embodiments, dibasic acids and esters (diesters) thereof and their use in passive heating and cooling applications are disclosed. In some embodiments, C18 dibasic acids and esters thereof are disclosed, including their use in passive heating and cooling applications. In some embodiments, various olefins, including alkenes and olefinic acids and esters, are disclosed, including their use in passive heating and cooling applications.